Cystic fibrosis-related diabetes in childhood

Hormone Research in Paediatrics

Volumn 73, Issue 1, 2010, Pages 15-24

  O'Riordan, Stephen M P ^a   Dattani, Mehul T ^a   Hindmarsh, Peter C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Children; Cystic fibrosis; Cystic fibrosis related diabetes; Diabetes

Indexed keywords

INSULIN;

CLINICAL FEATURE; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; HUMAN; INCIDENCE; INSULIN DEFICIENCY; INSULIN SENSITIVITY; INSULIN TREATMENT; LIFE EXPECTANCY; MEDLINE; MORBIDITY; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SURVIVAL;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC TECHNIQUES, ENDOCRINE; HUMANS; MODELS, BIOLOGICAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 77951476036     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000271912     Document Type: Short Survey

References (60)

1. Brennan AL, Geddes DM, Gyi KM, Baker EH: Clinical importance of cystic fibrosisrelated diabetes. J Cyst Fibros 2004; 3: 209-222.
2. Milla CE, Billings J, Moran A: Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005; 28: 2141-2144. (Pubitemid 41242458)
3. Moran A: Diagnosis, screening, and management of cystic fibrosis-related diabetes. Curr Diabetes Rep 2002; 2: 111-115.
4. Moran A: Cystic fibrosis-related diabetes: an approach to diagnosis and management. Pediatr Diabetes 2000; 1: 41-48.
5. Milla CE, Warwick WJ, Moran A: Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-895.
6. Hardin DS, Moran A: Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am 1999; 28: 787-800, ix.
7. Cystic Fibrosis Foundation: Cystic Fibrosis Foundation Patient Registry Annual Data Report. Bethesda, CFF, 2001.
8. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW 3rd, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Zipf WB, et al: Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61-73. (Pubitemid 29356125)
9. O'Riordan SM, Robinson PD, Donaghue KC, Moran A: ISPAD Clinical Practice Consensus Guidelines 2009 Compendium: management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 2009; 10: 43-50.
10. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC: Comparison of tests for glycated haemoglobin and fasting and two-hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994; 308: 1323-1328. (Pubitemid 2080582)
11. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C: Glucose tolerance in patients with cystic fibrosis: five-year prospective study. BMJ 1995; 311: 655-659. (Pubitemid 126523587)
12. Moran A, Doherty L, Wang X, Thomas W: Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998; 133: 10-17. (Pubitemid 28323899)
13. Lanng S: Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2001; 2: 253-259. (Pubitemid 34460746)
14. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A: Microvascular complications in cystic fibrosis related diabetes. Diabetes Care 2007; 30: 1056-1061. (Pubitemid 46684624)
15. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B: Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001; 32: 343-350. (Pubitemid 33015650)
16. O'Riordan S MPG, S. Hoey H, Costigan C: Demographics and prevalence of glucose intolerance and cystic fibrosis related diabetes in 167 cystic fibrosis children. Diabetes 2006; 55:A224-A224.
17. O'Riordan SGA, Ennis S, George S, Hand E, Costigan C, Murphy N, Roche E, Hoey H: Genetics of cystic fibrosis related diabetes and nondiabetes. Horm Res 2007; 68(suppl 1): 44-69.
18. Rosenecker J, Eichler I, Kuhn L, Harms HK, Von der Hardt H: Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatrics 1995; 127: 441-443.
19. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, Mastella G, Navarro J, Strandvik B, McKenzie S: European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001; 31: 1-12. (Pubitemid 32154734)
20. Lanng S, Thorsteinsson B, Pociot F, et al: Diabetes mellitus in cystic fibrosis: genetic and immunloogical markers. Acta Paediatr Scand 1993; 82: 150-154. (Pubitemid 23101484)
21. Jensen P, Johansen HK, Carmi P, Hoiby N, Cohen IR: Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis. J Autoimmun 2001; 17: 165-172. (Pubitemid 32928212)
22. Derbel S, Doumaguet C, Hubert D, Mosnier- Pudar H, Grabar S, Chelly J, Bienvenu T: Calpain and development of diabetes mellitus in cystic fibrosis. J Cyst Fibros 2006; 5: 47-51. (Pubitemid 43137161)
23. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC: Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996; 81: 1267-1272. (Pubitemid 26084003)
24. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP: Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715-723.
25. Holl RW, Heinze E, Wolf A, Rank M, Teller WM: Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995; 154: 356-361.
26. Hardin DS, Leblanc A, Marshall G, Seilheimer DK: Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001; 281:E1022-1028. (Pubitemid 33123810)
27. Moran AP, Pyzdrowski KL, Weinreb J, Kahn BB, Smith S A, Adams KS, Seaquist ER: Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43: 1020-1026. (Pubitemid 24230707)
28. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ: Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-377. (Pubitemid 18079818)
29. Lanng S, Thorsteinsson B, Nerup J, Koch C: Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-687.
30. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ: Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005; 146: 681-687. (Pubitemid 40616255)
31. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M: Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-519. (Pubitemid 32552133)
32. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M: Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867. (Pubitemid 32762829)
33. Rosenecker J, Hofler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt HG, Bargon J, von der Hardt H: Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001; 6: 345-350.
34. Sims EJ, Green MW, Mehta A: Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 2005; 28: 1581-1587. (Pubitemid 40923068)
35. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ: Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008; 152: 540-545, 545.e1. (Pubitemid 351381036)
36. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W: Cystic fibrosis-related diabetes: current trends in prevalence, incidence and mortality. Diabetes Care 2009;32: 1626-1631.
37. White H, Pollard K, Etherington C, Clifton I, Morton AM, Owen D, Conway SP, Peckham DG: Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention. J Cyst Fibros 2009; 8: 179-185.
38. Sullivan MM, Denning CR: Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989; 84: 642-647. (Pubitemid 19237564)
39. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C: Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-77. (Pubitemid 24072085)
40. Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME: Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998; 92: 871-872. (Pubitemid 28360617)
41. Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER: Cystic fibrosis-related diabetes - the presence of microvascular diabetes complications. Diabetes Care 2006; 29: 2660-2663. (Pubitemid 44912195)
42. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A: Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007; 30: 1056-1061. (Pubitemid 46684624)
43. Figueroa V, Milla C, Parks EJ, Schwarzenberg SJ, Moran A: Abnormal lipid concentrations in cystic fibrosis. Am J Clin Nutr 2002; 75: 1005-1011. (Pubitemid 34547529)
44. Rodman HM, Doershuk CF, Roland JM: The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine (Baltimore) 1986; 65: 389-397. (Pubitemid 17201720)
45. Robert JJ, Grasset E, de Montalembert M, Chevenne D, Deschamps I, Boitard C, Lenoir G: Research of factors for glucose intolerance in mucoviscidosis. Arch Fr Pediatr 1992; 49: 17-22.
46. Hartling SG, Garne S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C: Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test. Diabetes Res 1988; 7: 165-169. (Pubitemid 18081545)
47. Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C: Glucose tolerance in cystic fibrosis. Arch Dis Child 1991; 66: 612-616.
48. Swartz LM, Laffel LM: A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema. Pediatr Diabetes 2008; 9: 426-430.
49. Dodge JA, Turck D: Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol 2006; 20: 531-546. (Pubitemid 43890601)
50. Lanng S: Glucose intolerance in cystic fibrosis. Dan Med Bull 1997; 44: 23-39. (Pubitemid 27110210)
51. O'Riordan SM HP, Hill NR, Matthews DR, George S, Greally P, Canny G, Slattery D, Murphy N, Roche E, Costigan C, Hoey HMCV: Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis - a prospective cohort study. Diabetes Care 2009; 32: 1-3.
52. Borowitz D, Baker RD, Stallings V: Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 246-259.
53. Grover P, Thomas W, Moran A: Glargine versus NPH insulin in cystic fibrosis related diabetes. J Cyst Fibros 2008; 7: 134-136. (Pubitemid 351372762)
54. Hardin DS, Rice J, Rice M, Rosenblatt R: Use of the insulin pump in treating cystic fibrosis related diabetes. J Cyst Fibros 2009; 8: 174-178.
55. Reisman J, Corey M, Canny G, Levison H: Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990; 86: 374-377. (Pubitemid 20334969)
56. Onady GM, Stolfi A: Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2005; CD004730.
57. Moran A, Phillips J, Milla C: Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001; 24: 1706-1710. (Pubitemid 33716470)
58. Rosenecker J, Eichler I, Barmeier H, von der Hardt H: Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose- lowering agents. Pediatr Pulmonol 2001; 32: 351-355. (Pubitemid 33015651)
59. Kettler LJ, Sawyer SM, Winefield HR, Greville HW: Determinants of adherence in adults with cystic fibrosis. Thorax 2002; 57: 459-464. (Pubitemid 34494161)
60. Abbott J, Dodd M, Bilton D, Webb AK: Treatment compliance in adults with cystic fibrosis. Thorax 1994; 49: 115-119. (Pubitemid 24115442)